medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 1

<< Back Next >>

Ann Hepatol 2017; 16 (1)

Acute Hepatitis E Mimicking a Flare of Disease in a Patient with Chronic Autoimmune Hepatitis

Calisti G, Irish DN, Ijaz S, Tedder RS, Moore K

Language: English
References: 21
Page: 160-163
PDF size: 125.07 Kb.


ABSTRACT

Acute hepatitis E is becoming increasingly recognised in Europe with up to 40% of the population in Southern France being exposed to the virus, which is harboured in pigs. Patients with known liver disease may present with acute hepatitis E and present a diagnostic challenge. For example patients with autoimmune hepatitis (AIH) who are immunosuppressed and contract hepatitis E may be at increased risk of developing chronicity due to concurrent immunosuppression. Importantly, the diagnosis may be missed with the infection misdiagnosed as an autoimmune flare, and immunosuppression increased by the attending physician, thus enhancing the risk of chronicity of infection leading to progressive liver injury in immunocompromised patients.
We report a case of acute hepatitis E in a patient with AIH and discuss the features that helped us differentiating it from an autoimmune flare.


REFERENCES

  1. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44: 272-6. Doi: 10.1016/j.jcv.2009.01.005.

  2. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80: 289-93. Doi: 10.1002/jmv.21056.

  3. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009:200:48- 56. Doi: 10.1086/599319.

  4. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet 2012; 379: 2477-88. Doi: 10.1016/S0140-6736(11)61849-7.

  5. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-35. Doi: 10.1111/j.1365- 2036.2007.03504.x.

  6. Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011; 55: 171-82. Doi: 10.1016/j.jhep.2010.12.012.

  7. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-7. Doi: 10.1056/NEJMoa0706992.

  8. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361: 1025-7. Doi: 10.1056/NEJMc0903778.

  9. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with Tcell lymphoma. Hepatol Res 2007; 37: 113-20. Doi: 10.1111/ j.1872-034X.2007.00024.x.

  10. Giordani MT, Fabris P, Brunetti E, Goblirsch S, Romano L. Hepatitis E and lymphocytic leukemia in Man, Italy. Emerg Infect Dis 2013; 19: 2054-6. Doi: 10.3201/eid1912.130521.

  11. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013; 122: 1079-86. Doi: 10.1182/blood-2013-03-492363.

  12. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-76. Doi: 10.1002/hep.22322.

  13. Garson JA, Ferns RB, Grant PR, Ijaz S, Nastouli E, Szypulska R, Tedder RS, et al. Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results. J Virol Methods 2012; 186: 157-60. Doi: 10.1016/j.jviromet.2012.07.027.

  14. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, Dalton HR, et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192: 1166- 72. Doi: 10.1086/444396.

  15. Echevarria JM, Fogeda M, Avellon A. Epidemiology of hepatitis E virus infection in Spain. Enferm Infecc Microbiol Clin 2015; 33: 281-6. Doi: 10.1016/j.eimc.2013.11.009.

  16. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat 2014; 21: 78-89. Doi: 10.1111/jvh.12156.

  17. Höner zu Siederdissen C, Pischke S, Schlue J, Deterding K, Hellms T, Schuler-Lüttmann S, Schwarz A, et al. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology 2014; 60: 1112-3. Doi: 10.1002/hep.26987.

  18. Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology 2014; 59: 347-8. Doi: 10.1002/hep.26636.

  19. Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R1, Schlue J, Wursthorn K, et al. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One 2014; 9: e85330. Doi: 10.1371/journal.pone.0085330.

  20. van Gerven NM, van der Eijk AA, Pas SD, Zaaijer HL, de Boer YS, Witte BI, van Nieuwkerk CM, et al. Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands. J Gastrointestin Liver Dis 2016; 25: 9-13. doi: 10.15403/jgld.2014.1121.251.hpe.

  21. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 2015; 39: 20-7. doi: 10.1016/j.clinre.2014.07.005.




2020     |     www.medigraphic.com